{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:06:41Z","timestamp":1791346001267,"version":"4.3.1"},"reference-count":165,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1777,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CA: A Cancer Journal for Clinicians"],"published-print":{"date-parts":[[2010,11,1]]},"DOI":"10.3322\/caac.20082","type":"journal-article","created":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T01:48:47Z","timestamp":1287539327000},"page":"351-375","source":"Crossref","is-referenced-by-count":275,"title":["Inflammatory Breast Cancer: The Disease, the Biology, the Treatment"],"prefix":"10.1002","volume":"60","author":[{"given":"Fredika M.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Bondy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideko","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Kamrudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitri","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong","family":"Le-Petross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bidaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey N.","family":"Player","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford H.","family":"Barsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cristofanilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,20]]},"reference":[{"key":"10.3322\/caac.20082-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/1097-0142(197603)37:3<1422::AID-CNCR2820370325>3.0.CO;2-Y","article-title":"Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy","volume":"37","author":"Zucali","year":"1976","journal-title":"Cancer."},{"key":"10.3322\/caac.20082-BIB2|cit2","unstructured":"Bell C A system of operative surgery Hartford, CT Hale & Homser 1814"},{"key":"10.3322\/caac.20082-BIB3|cit3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/BD-2006-22105","article-title":"Clinical aspects of inflammatory breast cancer","volume":"22","author":"Walshe","year":"2005","journal-title":"Breast Dis."},{"key":"10.3322\/caac.20082-BIB4|cit4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)38056-X","article-title":"Peau d'orange in acute mammary carcinoma: its cause and diagnostic value","volume":"174","author":"Leitch","year":"1909","journal-title":"Lancet."},{"key":"10.3322\/caac.20082-BIB5|cit5","first-page":"347","volume-title":"Breast AJCC cancer staging manual","author":"Edge","year":"2010"},{"key":"10.3322\/caac.20082-BIB6|cit6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/1097-0142(197408)34:2<382::AID-CNCR2820340223>3.0.CO;2-M","article-title":"Clinically occult inflammatory carcinoma of the breast","volume":"34","author":"Saltzstein","year":"1974","journal-title":"Cancer."},{"key":"10.3322\/caac.20082-BIB7|cit7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ijc.2910620404","article-title":"Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?","volume":"62","author":"Bonnier","year":"1995","journal-title":"Int J Cancer."},{"key":"10.3322\/caac.20082-BIB8|cit8","first-page":"73","volume-title":"Cancer Management. A Multidisciplinary Approach","author":"Jardines","year":"1999"},{"key":"10.3322\/caac.20082-BIB9|cit9","first-page":"676","volume-title":"Inflammatory Carcinoma","author":"Rosen","year":"2001"},{"key":"10.3322\/caac.20082-BIB10|cit10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.seminoncol.2007.11.013","article-title":"Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis","volume":"35","author":"Resetkova","year":"2008","journal-title":"Semin Oncol."},{"key":"10.3322\/caac.20082-BIB11|cit11","first-page":"591","article-title":"Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2\/neu, pS2, cathepsin, ER and PR","volume":"12","author":"Charpin","year":"1992","journal-title":"Anticancer Res."},{"key":"10.3322\/caac.20082-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/1097-0142(197404)33:4<1045::AID-CNCR2820330422>3.0.CO;2-M","article-title":"Inflammatory carcinoma of the breast. A pathologic definition","volume":"33","author":"Ellis","year":"1974","journal-title":"Cancer."},{"key":"10.3322\/caac.20082-BIB13|cit13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/ajc.1938.33","article-title":"Inflammatory cancer of the breast","volume":"33","author":"Taylor","year":"1938","journal-title":"Am J Cancer."},{"key":"10.3322\/caac.20082-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/1097-0142(197804)41:4<1595::AID-CNCR2820410450>3.0.CO;2-Y","article-title":"Inflammatory carcinoma of the breast","volume":"41","author":"Lucas","year":"1978","journal-title":"Cancer."},{"key":"10.3322\/caac.20082-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/1097-0142(19801215)46:12<2741::AID-CNCR2820461234>3.0.CO;2-W","article-title":"Epidemiologic features of rapidly progressing breast cancer in Tunisia","volume":"46","author":"Mourali","year":"1980","journal-title":"Cancer."},{"key":"10.3322\/caac.20082-BIB16|cit16","first-page":"417","article-title":"Inflammatory carcinoma of the breast","volume":"87","author":"Meyer","year":"1948","journal-title":"Surg Gynecol Obstet."},{"key":"10.3322\/caac.20082-BIB17|cit17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1026512722789","article-title":"Inflammatory breast carcinoma: pathological or clinical entity?","volume":"64","author":"Amparo","year":"2000","journal-title":"Breast Cancer Res Treat."},{"key":"10.3322\/caac.20082-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1200\/JCO.2003.07.082","article-title":"Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?","volume":"21","author":"Anderson","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB19|cit19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1524-4741.2002.08509.x","article-title":"Lymphoma of the breast: clinical and radiologic features with pathologic correlation in 28 patients","volume":"8","author":"Sabate","year":"2002","journal-title":"Breast J."},{"key":"10.3322\/caac.20082-BIB20|cit20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2133.1993.tb11856.x","article-title":"Melanoma erysipeloides: inflammatory metastatic melanoma of the skin","volume":"129","author":"Tan","year":"1993","journal-title":"Br J Dermatol."},{"key":"10.3322\/caac.20082-BIB21|cit21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/BD-2006-22103","article-title":"Epidemiology of inflammatory breast cancer (IBC)","volume":"22","author":"Anderson","year":"2005","journal-title":"Breast Dis."},{"key":"10.3322\/caac.20082-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/jnci\/djm111","article-title":"Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population","volume":"99","author":"Kerlikowske","year":"2007","journal-title":"J Natl Cancer Inst."},{"key":"10.3322\/caac.20082-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","article-title":"The decrease in breast-cancer incidence in 2003 in the United States","volume":"356","author":"Ravdin","year":"2007","journal-title":"N Engl J Med."},{"key":"10.3322\/caac.20082-BIB24|cit24","article-title":"Cancer Statistics, 2010","author":"Jemal","year":"2010","journal-title":"CA: Cancer J Clin"},{"key":"10.3322\/caac.20082-BIB25|cit25","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnci\/dji172","article-title":"Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute","volume":"97","author":"Hance","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"10.3322\/caac.20082-BIB26|cit26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.seminoncol.2007.11.018","article-title":"The epidemiology of inflammatory breast cancer","volume":"35","author":"Levine","year":"2008","journal-title":"Semin Oncol."},{"key":"10.3322\/caac.20082-BIB27|cit27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/1097-0142(197707)40:1<376::AID-CNCR2820400153>3.0.CO;2-Y","article-title":"Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia","volume":"40","author":"Tabbane","year":"1977","journal-title":"Cancer."},{"key":"10.3322\/caac.20082-BIB28|cit28","doi-asserted-by":"crossref","unstructured":"Bondy M Cristofanilli M El-Zein R Wiggins S Lara J Jackson S A Progress Review of the Inflammatory Breast Cancer Registry at the University of Texas M.D. Anderson Cancer Center 2009","DOI":"10.1158\/0008-5472.SABCS-09-2073"},{"key":"10.3322\/caac.20082-BIB29|cit29","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1200\/JCO.1998.16.12.3731","article-title":"Inflammatory breast cancer and body mass index","volume":"16","author":"Chang","year":"1998","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB30|cit30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1524-4741.2001.07604.x","article-title":"Case control study of prognostic markers and disease outcome in inflammatory carcinoma breast: a unique clinical experience","volume":"7","author":"Aziz","year":"2001","journal-title":"Breast J."},{"key":"10.3322\/caac.20082-BIB31|cit31","first-page":"U1566","article-title":"Inflammatory breast cancer in a male","volume":"118","author":"Choueiri","year":"2005","journal-title":"N Z Med J."},{"key":"10.3322\/caac.20082-BIB32|cit32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-007-9671-z","article-title":"Inflammatory breast cancer: PET\/CT, MRI, mammography, and sonography findings","volume":"109","author":"Yang","year":"2008","journal-title":"Breast Cancer Res Treat."},{"key":"10.3322\/caac.20082-BIB33|cit33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/BD-2006-22106","article-title":"Imaging in inflammatory breast carcinoma","volume":"22","author":"Chow","year":"2005","journal-title":"Breast Dis."},{"key":"10.3322\/caac.20082-BIB34|cit34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1148\/radiol.2233010198","article-title":"Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases","volume":"223","author":"Gunhan-Bilgen","year":"2002","journal-title":"Radiology."},{"key":"10.3322\/caac.20082-BIB35|cit35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7863\/jum.1996.15.3.241","article-title":"High resolution sonographic detection of axillary lymph node metastases in breast cancer","volume":"15","author":"Yang","year":"1996","journal-title":"J Ultrasound Med."},{"key":"10.3322\/caac.20082-BIB36|cit36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9610(00)00382-2","article-title":"The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy","volume":"179","author":"Vlastos","year":"2000","journal-title":"Am J Surg."},{"key":"10.3322\/caac.20082-BIB37|cit37","first-page":"22","article-title":"Inflammatory breast cancer: imaging findings","volume":"29","author":"Lee","year":"2005","journal-title":"Clin Imaging."},{"key":"10.3322\/caac.20082-BIB38|cit38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.acra.2007.09.011","article-title":"Inflammatory breast carcinoma in magnetic resonance imaging a comparison with locally advanced breast cancer","volume":"15","author":"Renz","year":"2008","journal-title":"Acad Radiol."},{"key":"10.3322\/caac.20082-BIB39|cit39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004728-199701000-00025","article-title":"MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up","volume":"21","author":"Rieber","year":"1997","journal-title":"J Comput Assist Tomogr."},{"key":"10.3322\/caac.20082-BIB40|cit40","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1245\/s10434-008-0141-6","article-title":"Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response?","volume":"15","author":"Chen","year":"2008","journal-title":"Ann Surg Oncol."},{"issue":"2 suppl","key":"10.3322\/caac.20082-BIB41|cit41","article-title":"Inflammatory breast cancer: defining breast magnetic resonance imaging features","volume":"69","author":"Le-Petross","year":"2009","journal-title":"Cancer Res."},{"key":"10.3322\/caac.20082-BIB42|cit42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1148\/radiol.2443060926","article-title":"Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab-initial experience","volume":"244","author":"Thukral","year":"2007","journal-title":"Radiology."},{"key":"10.3322\/caac.20082-BIB43|cit43","first-page":"299","article-title":"Role of magnetic resonance imaging in inflammatory carcinoma of the breast","volume":"27","author":"Belli","year":"2002","journal-title":"Rays."},{"key":"10.3322\/caac.20082-BIB44|cit44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0009-9260(82)80407-8","article-title":"Patterns of breast skin thickness In normal mammograms","volume":"33","author":"Willson","year":"1982","journal-title":"Clin Radiol."},{"key":"10.3322\/caac.20082-BIB45|cit45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1022153327339","article-title":"Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI","volume":"78","author":"Cheung","year":"2003","journal-title":"Breast Cancer Res Treat."},{"key":"10.3322\/caac.20082-BIB46|cit46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.mric.2006.09.001","article-title":"MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy","volume":"14","author":"Hylton","year":"2006","journal-title":"Magn Reson Imaging Clin N Am."},{"key":"10.3322\/caac.20082-BIB47|cit47","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1200\/JCO.2005.03.4645","article-title":"Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer","volume":"24","author":"Wedam","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB48|cit48","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1200\/JCO.2007.11.9610","article-title":"Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology","volume":"25","author":"Hamstra","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2214\/ajr.181.5.1811275","article-title":"Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy","volume":"181","author":"Rosen","year":"2003","journal-title":"AJR Am J Roentgenol."},{"key":"10.3322\/caac.20082-BIB50|cit50","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/jmri.1124","article-title":"MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation","volume":"13","author":"Weatherall","year":"2001","journal-title":"J Magn Reson Imaging."},{"key":"10.3322\/caac.20082-BIB51|cit51","first-page":"1369","article-title":"A combined PET\/CT scanner for clinical oncology","volume":"41","author":"Beyer","year":"2000","journal-title":"J Nucl Med."},{"key":"10.3322\/caac.20082-BIB52|cit52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1019664126220","article-title":"The role of 18F-FDG-PET in the local\/regional evaluation of women with breast cancer","volume":"75","author":"Danforth","year":"2002","journal-title":"Breast Cancer Res Treat."},{"key":"10.3322\/caac.20082-BIB53|cit53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.semnuclmed.2004.11.001","article-title":"Evolving role of positron emission tomography in breast cancer imaging","volume":"35","author":"Eubank","year":"2005","journal-title":"Semin Nucl Med."},{"key":"10.3322\/caac.20082-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1200\/JCO.2004.07.058","article-title":"18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer","volume":"22","author":"van der Hoeven","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB55|cit55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.coc.0000128869.19357.9b","article-title":"Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC)","volume":"27","author":"Bellon","year":"2004","journal-title":"Am J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB56|cit56","first-page":"1455","article-title":"18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome","volume":"46","author":"Tran","year":"2005","journal-title":"J Nucl Med."},{"key":"10.3322\/caac.20082-BIB57|cit57","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2967\/jnumed.108.056010","article-title":"Retrospective study of 18F-FDG PET\/CT in the diagnosis of inflammatory breast cancer: preliminary data","volume":"50","author":"Carkaci","year":"2009","journal-title":"J Nucl Med."},{"key":"10.3322\/caac.20082-BIB58|cit58","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1200\/JCO.2006.06.5599","article-title":"Measures of response: RECIST, WHO, and new alternatives","volume":"24","author":"Jaffe","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB59|cit59","volume-title":"Imaging as a biomarker: standards for change measurements in therapy","year":"2006"},{"key":"10.3322\/caac.20082-BIB60|cit60","first-page":"1806","article-title":"Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy","volume":"44","author":"Mankoff","year":"2003","journal-title":"J Nucl Med."},{"key":"10.3322\/caac.20082-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2000.18.8.1689","article-title":"Positron emission tomography using [F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer","volume":"18","author":"Schelling","year":"2000","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB62|cit62","first-page":"931","article-title":"Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer","volume":"37","author":"Bassa","year":"1996","journal-title":"J Nucl Med."},{"key":"10.3322\/caac.20082-BIB63|cit63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1075-122X.2006.00269.x","article-title":"High-resolution fluorodeoxyglucose positron emission tomography with compression (\u201cpositron emission mammography\u201d) is highly accurate in depicting primary breast cancer","volume":"12","author":"Berg","year":"2006","journal-title":"Breast J."},{"key":"10.3322\/caac.20082-BIB64|cit64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nm1467","article-title":"Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging","volume":"13","author":"Lee","year":"2007","journal-title":"Nat Med."},{"key":"10.3322\/caac.20082-BIB65|cit65","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/153303460400300410","article-title":"Lighting up tumors with receptor-specific optical molecular probes","volume":"3","author":"Achilefu","year":"2004","journal-title":"Technol Cancer Res Treat."},{"key":"10.3322\/caac.20082-BIB66|cit66","first-page":"2723","article-title":"Magnetic resonance molecular imaging of the HER-2\/neu receptor","volume":"63","author":"Artemov","year":"2003","journal-title":"Cancer Res."},{"key":"10.3322\/caac.20082-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1158\/1535-7163.MCT-06-0741","article-title":"Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts","volume":"6","author":"Rosenthal","year":"2007","journal-title":"Mol Cancer Ther."},{"key":"10.3322\/caac.20082-BIB68|cit68","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jcb.10616","article-title":"Real time non-invasive imaging of receptor-ligand interactions in vivo","volume":"90","author":"Winnard","year":"2003","journal-title":"J Cell Biochem."},{"key":"10.3322\/caac.20082-BIB69|cit69","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/1078-0432.CCR-0688-3","article-title":"Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging","volume":"10","author":"Rajendran","year":"2004","journal-title":"Clin Cancer Res."},{"key":"10.3322\/caac.20082-BIB70|cit70","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1109\/51.195938","article-title":"Medical image matching-a review with classification","volume":"12","author":"van den Elsen","year":"1993","journal-title":"IEEE Eng Med Biol Mag."},{"key":"10.3322\/caac.20082-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1361-8415(01)80026-8","article-title":"A survey of medical image registration","volume":"2","author":"Maintz","year":"1998","journal-title":"Med Image Anal."},{"key":"10.3322\/caac.20082-BIB72|cit72","series-title":"Handbook of Medical Imaging","volume-title":"Medical Image Processing and Analysis","volume":"2","author":"Bankman","year":"2000"},{"key":"10.3322\/caac.20082-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.neuroimage.2003.07.014","article-title":"Zen and the art of medical image registration: correspondence, homology, and quality","volume":"20","author":"Crum","year":"2003","journal-title":"Neuroimage."},{"issue":"Spec No 2","key":"10.3322\/caac.20082-BIB74|cit74","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1259\/bjr\/25329214","article-title":"Non-rigid image registration: theory and practice","volume":"77","author":"Crum","year":"2004","journal-title":"Br J Radiol."},{"key":"10.3322\/caac.20082-BIB75|cit75","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/104687810103200307","article-title":"Multisensor imaging and virtual simulation for assessment, diagnosis, therapy planning, and navigation","volume":"32","author":"Bidaut","year":"2001","journal-title":"Simulation & Gaming."},{"key":"10.3322\/caac.20082-BIB76|cit76","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.semtcvs.2004.08.011","article-title":"Advanced imaging including PET\/CT for cardiothoracic surgery","volume":"16","author":"Bidaut","year":"2004","journal-title":"Semin Thorac Cardiovasc Surg."},{"key":"10.3322\/caac.20082-BIB77|cit77","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-005-9015-9","article-title":"Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling","volume":"95","author":"Van Laere","year":"2006","journal-title":"Breast Cancer Res Treat."},{"key":"10.3322\/caac.20082-BIB78|cit78","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1158\/1078-0432.CCR-04-0202","article-title":"p53 expression as a prognostic marker in inflammatory breast cancer","volume":"10","author":"Gonzalez-Angulo","year":"2004","journal-title":"Clin Cancer Res."},{"key":"10.3322\/caac.20082-BIB79|cit79","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.2910430205","article-title":"Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance","volume":"43","author":"Guerin","year":"1989","journal-title":"Int J Cancer."},{"key":"10.3322\/caac.20082-BIB80|cit80","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjc.6603906","article-title":"NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and\/or ErbB2 overexpression and MAPK hyperactivation","volume":"97","author":"Van Laere","year":"2007","journal-title":"Br J Cancer."},{"key":"10.3322\/caac.20082-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/annonc\/mdm060","article-title":"Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer","volume":"18","author":"Cabioglu","year":"2007","journal-title":"Ann Oncol."},{"key":"10.3322\/caac.20082-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/sj.bjc.6695007","article-title":"Molecular cytogenetic analysis of 11 new breast cancer cell lines","volume":"81","author":"Forozan","year":"1999","journal-title":"Br J Cancer."},{"key":"10.3322\/caac.20082-BIB83|cit83","first-page":"2511","article-title":"A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype","volume":"5","author":"van Golen","year":"1999","journal-title":"Clin Cancer Res."},{"key":"10.3322\/caac.20082-BIB84|cit84","first-page":"5832","article-title":"RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype","volume":"60","author":"van Golen","year":"2000","journal-title":"Cancer Res."},{"key":"10.3322\/caac.20082-BIB85|cit85","first-page":"575","article-title":"Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor","volume":"1","author":"van Golen","year":"2002","journal-title":"Mol Cancer Ther."},{"key":"10.3322\/caac.20082-BIB86|cit86","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1158\/1078-0432.CCR-08-2658","article-title":"Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer","volume":"15","author":"Sparano","year":"2009","journal-title":"Clin Cancer Res."},{"key":"10.3322\/caac.20082-BIB87|cit87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1593\/neo.03316","article-title":"WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer","volume":"6","author":"Kleer","year":"2004","journal-title":"Neoplasia."},{"key":"10.3322\/caac.20082-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","article-title":"Role of the insulin-like growth factor family in cancer development and progression","volume":"92","author":"Yu","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"10.3322\/caac.20082-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1158\/1078-0432.CCR-07-1479","article-title":"Prognostic value of body mass index in locally advanced breast cancer","volume":"14","author":"Dawood","year":"2008","journal-title":"Clin Cancer Res."},{"key":"10.3322\/caac.20082-BIB90|cit90","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.coph.2008.07.004","article-title":"Targeting insulin and insulin-like growth factor signalling in oncology","volume":"8","author":"Pollak","year":"2008","journal-title":"Curr Opin Pharmacol."},{"key":"10.3322\/caac.20082-BIB91|cit91","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1535-7163.MCT-09-0381","article-title":"Molecular predictors of response to a humanized anti-insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer","volume":"8","author":"Zha","year":"2009","journal-title":"Mol Cancer Ther."},{"key":"10.3322\/caac.20082-BIB92|cit92","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","article-title":"Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer","volume":"27","author":"Jiralerspong","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB93|cit93","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.22.1630","article-title":"Metformin in breast cancer: time for action","volume":"27","author":"Goodwin","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB94|cit94","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1158\/1078-0432.CCR-04-0063","article-title":"Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification","volume":"10","author":"Van der Auwera","year":"2004","journal-title":"Clin Cancer Res."},{"key":"10.3322\/caac.20082-BIB95|cit95","first-page":"503","article-title":"Cyclooxygenase-2 gene expression in human breast cancer","volume":"10","author":"Parrett","year":"1997","journal-title":"Int J Oncol."},{"key":"10.3322\/caac.20082-BIB96|cit96","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrc2622","article-title":"Metastasis: from dissemination to organ-specific colonization","volume":"9","author":"Nguyen","year":"2009","journal-title":"Nat Rev Cancer."},{"key":"10.3322\/caac.20082-BIB97|cit97","first-page":"299","article-title":"Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells","volume":"7","author":"Robertson","year":"2008","journal-title":"J Exp Ther Oncol."},{"key":"10.3322\/caac.20082-BIB98|cit98","first-page":"506","article-title":"Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment","volume":"50","author":"de M Souza","year":"2009","journal-title":"Can Vet J."},{"key":"10.3322\/caac.20082-BIB99|cit99","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjc.6690114","article-title":"Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6","volume":"79","author":"Kurebayashi","year":"1999","journal-title":"Br J Cancer."},{"key":"10.3322\/caac.20082-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1349-7006.2009.01197.x","article-title":"Antitumor activity of a dual epidermal growth factor receptor and ErbB2 kinase inhibitor MP-412 (AV-412) in mouse xenograft models","volume":"100","author":"Suzuki","year":"2009","journal-title":"Cancer Sci."},{"key":"10.3322\/caac.20082-BIB101|cit101","first-page":"5079","article-title":"A novel human xenograft model of inflammatory breast cancer","volume":"59","author":"Alpaugh","year":"1999","journal-title":"Cancer Res."},{"key":"10.3322\/caac.20082-BIB102|cit102","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/modpathol.3880334","article-title":"Persistent E-cadherin expression in inflammatory breast cancer","volume":"14","author":"Kleer","year":"2001","journal-title":"Mod Pathol."},{"key":"10.3322\/caac.20082-BIB103|cit103","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/B:BREA.0000021028.33926.a8","article-title":"Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer","volume":"85","author":"Van den Eynden","year":"2004","journal-title":"Breast Cancer Res Treat."},{"key":"10.3322\/caac.20082-BIB104|cit104","first-page":"5231","article-title":"An intact overexpressed E-cadherin\/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma","volume":"61","author":"Tomlinson","year":"2001","journal-title":"Cancer Res."},{"key":"10.3322\/caac.20082-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest."},{"key":"10.3322\/caac.20082-BIB106|cit106","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1089\/104303402320139023","article-title":"Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo","volume":"13","author":"Alpaugh","year":"2002","journal-title":"Hum Gene Ther."},{"key":"10.3322\/caac.20082-BIB107|cit107","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00432-006-0140-6","article-title":"Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro","volume":"133","author":"Dong","year":"2007","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.3322\/caac.20082-BIB108|cit108","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/ncb1900","article-title":"Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer","volume":"11","author":"Silvera","year":"2009","journal-title":"Nat Cell Biol."},{"key":"10.3322\/caac.20082-BIB109|cit109","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am J Pathol."},{"key":"10.3322\/caac.20082-BIB110|cit110","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1038\/sj.onc.1206447","article-title":"Molecular plasticity of human melanoma cells","volume":"22","author":"Hendrix","year":"2003","journal-title":"Oncogene."},{"key":"10.3322\/caac.20082-BIB111|cit111","first-page":"560","article-title":"Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft","volume":"62","author":"Shirakawa","year":"2002","journal-title":"Cancer Res."},{"key":"10.3322\/caac.20082-BIB112|cit112","article-title":"Histological, immunohistological and ultrastructural description of vasculogenic mimicry in canine mammary cancer","author":"Clemente","journal-title":"Vet Pathol."},{"key":"10.3322\/caac.20082-BIB113|cit113","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.cellbio.22.010305.104154","article-title":"The biology of cancer stem cells","volume":"23","author":"Lobo","year":"2007","journal-title":"Annu Rev Cell Dev Biol."},{"key":"10.3322\/caac.20082-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.1061803","article-title":"In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells","volume":"17","author":"Dontu","year":"2003","journal-title":"Genes Dev."},{"key":"10.3322\/caac.20082-BIB115|cit115","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr1982","article-title":"Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy","volume":"10","author":"Fillmore","year":"2008","journal-title":"Breast Cancer Res."},{"key":"10.3322\/caac.20082-BIB116|cit116","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","article-title":"Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature","volume":"69","author":"Charafe-Jauffret","year":"2009","journal-title":"Cancer Res."},{"key":"10.3322\/caac.20082-BIB117|cit117","doi-asserted-by":"crossref","first-page":"e1000121","DOI":"10.1371\/journal.pbio.1000121","article-title":"Regulation of mammary stem\/progenitor cells by PTEN\/Akt\/beta-catenin signaling","volume":"7","author":"Korkaya","year":"2009","journal-title":"PLoS Biol."},{"key":"10.3322\/caac.20082-BIB118|cit118","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2353\/ajpath.2008.071214","article-title":"The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype","volume":"173","author":"Xiao","year":"2008","journal-title":"Am J Pathol."},{"key":"10.3322\/caac.20082-BIB119|cit119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat Rev Cancer."},{"key":"10.3322\/caac.20082-BIB120|cit120","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell."},{"key":"10.3322\/caac.20082-BIB121|cit121","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1158\/1078-0432.CCR-09-0951","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and Inhibits Metastasis in Inflammatory Breast Cancer","volume":"15","author":"Zhang","year":"2009","journal-title":"Clinical Cancer Res."},{"key":"10.3322\/caac.20082-BIB122|cit122","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1158\/0008-5472.CAN-09-2111","article-title":"Metastamir: the field of metastasis-regulatory microRNA is spreading","volume":"69","author":"Hurst","year":"2009","journal-title":"Cancer Res."},{"key":"10.3322\/caac.20082-BIB123|cit123","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002800050664","article-title":"Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center","volume":"40","author":"Ueno","year":"1997","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.3322\/caac.20082-BIB124|cit124","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3816\/CBC.2004.n.042","article-title":"Long-term results of combined-modality therapy for inflammatory breast carcinoma","volume":"5","author":"Baldini","year":"2004","journal-title":"Clin Breast Cancer."},{"key":"10.3322\/caac.20082-BIB125|cit125","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/1097-0142(20011001)92:7<1775::AID-CNCR1693>3.0.CO;2-E","article-title":"Paclitaxel in the multimodality treatment for inflammatory breast carcinoma","volume":"92","author":"Cristofanilli","year":"2001","journal-title":"Cancer."},{"key":"10.3322\/caac.20082-BIB126|cit126","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3816\/CBC.2004.n.004","article-title":"Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience","volume":"4","author":"Cristofanilli","year":"2004","journal-title":"Clin Breast Cancer."},{"key":"10.3322\/caac.20082-BIB127|cit127","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.1999.17.2.460","article-title":"Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy","volume":"17","author":"Kuerer","year":"1999","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB128|cit128","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0360-3016(02)04201-3","article-title":"Ten-year outcome after combined modality therapy for inflammatory breast cancer","volume":"55","author":"Harris","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.3322\/caac.20082-BIB129|cit129","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/cncr.21726","article-title":"Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy","volume":"106","author":"Hennessy","year":"2006","journal-title":"Cancer."},{"key":"10.3322\/caac.20082-BIB130|cit130","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med."},{"key":"10.3322\/caac.20082-BIB131|cit131","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med."},{"key":"10.3322\/caac.20082-BIB132|cit132","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med."},{"key":"10.3322\/caac.20082-BIB133|cit133","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1200\/JCO.2005.07.032","article-title":"Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer","volume":"23","author":"Buzdar","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB134|cit134","first-page":"131","article-title":"Strong association between c-myb and oestrogen-receptor expression in human breast cancer","volume":"5","author":"Guerin","year":"1990","journal-title":"Oncogene."},{"key":"10.3322\/caac.20082-BIB135|cit135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.breast.2003.08.004","article-title":"High incidence of HER-2 positivity in inflammatory breast cancer","volume":"13","author":"Parton","year":"2004","journal-title":"Breast."},{"key":"10.3322\/caac.20082-BIB136|cit136","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1200\/JCO.2005.02.8886","article-title":"Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer","volume":"24","author":"Hurley","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB137|cit137","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3816\/CBC.2003.n.040","article-title":"Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results","volume":"4","author":"Van Pelt","year":"2003","journal-title":"Clin Breast Cancer."},{"key":"10.3322\/caac.20082-BIB138|cit138","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1200\/JCO.2003.03.124","article-title":"Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin\/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study","volume":"21","author":"Burstein","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB139|cit139","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0140-6736(09)61964-4","article-title":"Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort","volume":"375","author":"Gianni","journal-title":"Lancet."},{"key":"10.3322\/caac.20082-BIB140|cit140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/BD-2006-22108","article-title":"Surgical aspects of inflammatory breast cancer","volume":"22","author":"Kell","year":"2005","journal-title":"Breast Dis."},{"key":"10.3322\/caac.20082-BIB141|cit141","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF02303668","article-title":"Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma","volume":"4","author":"Fleming","year":"1997","journal-title":"Ann Surg Oncol."},{"key":"10.3322\/caac.20082-BIB142|cit142","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10434-999-0249-3","article-title":"Beyond palliative mastectomy in inflammatory breast cancer-a reassessment of margin status","volume":"6","author":"Curcio","year":"1999","journal-title":"Ann Surg Oncol."},{"key":"10.3322\/caac.20082-BIB143|cit143","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijrobp.2008.01.039","article-title":"Locoregional treatment outcomes after multimodality management of inflammatory breast cancer","volume":"72","author":"Bristol","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.3322\/caac.20082-BIB144|cit144","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0360-3016(89)90060-6","article-title":"Multimodal treatment for inflammatory breast cancer","volume":"17","author":"Thoms","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.3322\/caac.20082-BIB145|cit145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0360-3016(99)00019-X","article-title":"Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation","volume":"44","author":"Arthur","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.3322\/caac.20082-BIB146|cit146","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3816\/CBC.2006.n.045","article-title":"Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancer","volume":"7","author":"Gonzalez-Angulo","year":"2006","journal-title":"Clin Breast Cancer."},{"key":"10.3322\/caac.20082-BIB147|cit147","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrclinonc.2009.73","article-title":"Molecular targets for treatment of inflammatory breast cancer","volume":"6","author":"Yamauchi","year":"2009","journal-title":"Nat Rev Clin Oncol."},{"key":"10.3322\/caac.20082-BIB148|cit148","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.seminoncol.2007.11.015","article-title":"Defining the molecular biology of inflammatory breast cancer","volume":"35","author":"Charafe-Jauffret","year":"2008","journal-title":"Semin Oncol."},{"key":"10.3322\/caac.20082-BIB149|cit149","article-title":"Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib in combination with paclitaxel in patients with newly diagnosed inflammatory breast cancer","author":"Boussen","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB150|cit150","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1056\/NEJMoa064320","article-title":"Lapatinib plus capecitabine for HER2-positive advanced breast cancer","volume":"355","author":"Geyer","year":"2006","journal-title":"N Engl J Med."},{"key":"10.3322\/caac.20082-BIB151|cit151","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10456-005-9010-0","article-title":"Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro","volume":"8","author":"Weigand","year":"2005","journal-title":"Angiogenesis."},{"key":"10.3322\/caac.20082-BIB152|cit152","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.1200\/jco.2007.25.18_suppl.11078","article-title":"In vivo response-adapted dose-dense (dd) doxorubicin and cyclophosphamide (AC) -> weekly carboplatin and albumin-bound paclitaxel (nab-TC)\/trastuzumab (H)\/bevacizumab (B) in large and inflammatory breast cancer (BC): A phase II study","volume":"25","author":"Bernstein","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB153|cit153","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1158\/1078-0432.CCR-07-0688","article-title":"Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin","volume":"13","author":"Overmoyer","year":"2007","journal-title":"Clin Cancer Res."},{"key":"10.3322\/caac.20082-BIB154|cit154","unstructured":"2010 http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00558103"},{"key":"10.3322\/caac.20082-BIB155|cit155","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/sj.bjc.6603120","article-title":"Targeting lymphangiogenesis to prevent tumour metastasis","volume":"94","author":"Achen","year":"2006","journal-title":"Br J Cancer."},{"key":"10.3322\/caac.20082-BIB156|cit156","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/bcr585","article-title":"Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model","volume":"5","author":"Shirakawa","year":"2003","journal-title":"Breast Cancer Res."},{"key":"10.3322\/caac.20082-BIB157|cit157","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/bcr755","article-title":"WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer","volume":"6","author":"Kleer","year":"2004","journal-title":"Breast Cancer Res."},{"key":"10.3322\/caac.20082-BIB158|cit158","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.279.5350.509","article-title":"Rho GTPases and the actin cytoskeleton","volume":"279","author":"Hall","year":"1998","journal-title":"Science."},{"key":"10.3322\/caac.20082-BIB159|cit159","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1200\/JCO.1999.17.11.3631","article-title":"Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development","volume":"17","author":"Rowinsky","year":"1999","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB160|cit160","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0006-2952(00)00386-5","article-title":"Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics","volume":"60","author":"Cohen","year":"2000","journal-title":"Biochem Pharmacol."},{"key":"10.3322\/caac.20082-BIB161|cit161","unstructured":"http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00049114 2002"},{"key":"10.3322\/caac.20082-BIB162|cit162","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1200\/JCO.2004.10.147","article-title":"Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy","volume":"22","author":"Somlo","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.3322\/caac.20082-BIB163|cit163","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.bjc.6690714","article-title":"First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)","volume":"81","author":"Viens","year":"1999","journal-title":"Br J Cancer."},{"key":"10.3322\/caac.20082-BIB164|cit164","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0360-3016(00)00561-7","article-title":"Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence","volume":"47","author":"Liao","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.3322\/caac.20082-BIB165|cit165","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00000421-199210000-00002","article-title":"Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy","volume":"15","author":"Pisansky","year":"1992","journal-title":"Am J Clin Oncol."}],"container-title":["CA: A Cancer Journal for Clinicians"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.3322%2Fcaac.20082","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T02:09:56Z","timestamp":1592014196000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.3322\/caac.20082"},"secondary":[{"URL":"http:\/\/doi.wiley.com\/10.3322\/caac.20082","label":"WILEY_SECONDARY"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,20]]},"references-count":165,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11,1]]}},"URL":"https:\/\/doi.org\/10.3322\/caac.20082","relation":{},"ISSN":["0007-9235"],"issn-type":[{"value":"0007-9235","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10,20]]}}}